OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Managing cystic fibrosis in children aged 6-11yrs: a critical review of elexacaftor/tezacaftor/ivacaftor combination therapy
Kamyron Jordan, Edith T. Zemanick, Jennifer L. Taylor‐Cousar, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 2, pp. 97-108
Closed Access | Times Cited: 9
Kamyron Jordan, Edith T. Zemanick, Jennifer L. Taylor‐Cousar, et al.
Expert Review of Respiratory Medicine (2023) Vol. 17, Iss. 2, pp. 97-108
Closed Access | Times Cited: 9
Showing 9 citing articles:
Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508del Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor
Vito Terlizzi, Cristina Fevola, Santiago Presti, et al.
The Journal of Pediatrics (2024) Vol. 274, pp. 114176-114176
Closed Access | Times Cited: 7
Vito Terlizzi, Cristina Fevola, Santiago Presti, et al.
The Journal of Pediatrics (2024) Vol. 274, pp. 114176-114176
Closed Access | Times Cited: 7
Longitudinal profiling of the intestinal microbiome in children with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor
Seth A. Reasoner, Rachel Bernard, Adam Waalkes, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 6
Seth A. Reasoner, Rachel Bernard, Adam Waalkes, et al.
mBio (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 6
Long-Term Impact of Elexacaftor/Tezacaftor/Ivacaftor on Small and Large Airways in People with Cystic Fibrosis Aged ≥ 6 Years: 24-Month Real-World Evidence from the German CF Registry
Stefanie Dillenhöfer, Katharina Schütz, Manuel Burkhart, et al.
(2025)
Closed Access
Stefanie Dillenhöfer, Katharina Schütz, Manuel Burkhart, et al.
(2025)
Closed Access
Cystic fibrosis management in pediatric population—from clinical features to personalized therapy
Alice Azoicăi, Ancuța Lupu, Laura Mihaela Trandafir, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 1
Alice Azoicăi, Ancuța Lupu, Laura Mihaela Trandafir, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 1
Diagnostic and Communication Challenges in Cystic Fibrosis Newborn Screening
J. DeCelie-Germana, Lynn Bonitz, E. Langfelder-Schwind, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1646-1646
Open Access | Times Cited: 3
J. DeCelie-Germana, Lynn Bonitz, E. Langfelder-Schwind, et al.
Life (2023) Vol. 13, Iss. 8, pp. 1646-1646
Open Access | Times Cited: 3
Diabetes and prediabetes in children with cystic fibrosis
Riccardo Schiaffini, Valentina Pampanini
Current Opinion in Pediatrics (2023) Vol. 35, Iss. 4, pp. 481-485
Open Access | Times Cited: 1
Riccardo Schiaffini, Valentina Pampanini
Current Opinion in Pediatrics (2023) Vol. 35, Iss. 4, pp. 481-485
Open Access | Times Cited: 1
A Novel 7H-[1,2,4]Triazolo[3,4-b]thiadiazine-based Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Directed toward Treatment of Cystic Fibrosis
András Rab, Yang Xun, William F. Tracy, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 10, pp. 1338-1343
Open Access | Times Cited: 1
András Rab, Yang Xun, William F. Tracy, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 10, pp. 1338-1343
Open Access | Times Cited: 1
An Update in Cystic Fibrosis-Related Diabetes in Children and Adolescents
Dana-Teodora Anton-Păduraru, Alina Murgu, Mădălina Andreea Donos, et al.
Children (2023) Vol. 10, Iss. 12, pp. 1879-1879
Open Access | Times Cited: 1
Dana-Teodora Anton-Păduraru, Alina Murgu, Mădălina Andreea Donos, et al.
Children (2023) Vol. 10, Iss. 12, pp. 1879-1879
Open Access | Times Cited: 1
Longitudinal Profiling of the Intestinal Microbiome in Children with Cystic Fibrosis Treated with Elexacaftor-Tezacaftor-Ivacaftor
Seth A. Reasoner, Rachel Bernard, Adam Waalkes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Seth A. Reasoner, Rachel Bernard, Adam Waalkes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
